13D/13G Filings - BML Investment Partners, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...5, 6, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-05-30
5:46 pm
Sale
2025-05-28 13D AN2 Therapeutics, Inc.
ANTX
BML Investment Partners, L.P. 3,217,423
10.700%
-2,532,009decrease
(-44.04%)
Filing
History
2025-05-20
08:27 am
Purchase
2025-05-19 13D Adverum Biotechnologies, Inc.
ADVM
BML Investment Partners, L.P. 3,249,326
15.600%
367,009increase
(+12.73%)
Filing
History
2025-05-07
10:27 am
Unchanged
2025-05-07 13D AN2 Therapeutics, Inc.
ANTX
BML Investment Partners, L.P. 5,749,432
19.100%
0
(Unchanged)
Filing
History
2025-05-06
09:15 am
Purchase
2025-03-31 13G Adverum Biotechnologies, Inc.
ADVM
BML Investment Partners, L.P. 2,882,317
13.800%
508,913increase
(+21.44%)
Filing
History
2025-04-24
08:56 am
Unchanged
2025-04-24 13D ESSA Pharma Inc.
EPIX
BML Investment Partners, L.P. 4,221,546
9.500%
0
(Unchanged)
Filing
History
2025-04-16
09:16 am
Unchanged
2025-04-16 13D Elevation Oncology, Inc.
ELEV
BML Investment Partners, L.P. 5,890,934
9.900%
0
(Unchanged)
Filing
History
2025-03-26
7:11 pm
Purchase
2025-03-21 13G Elevation Oncology, Inc.
ELEV
BML Investment Partners, L.P. 5,890,934
9.900%
5,890,934increase
(New Position)
Filing
History
2025-03-06
5:46 pm
Purchase
2025-02-28 13G Kezar Life Sciences, Inc.
KZR
BML Investment Partners, L.P. 368,594
5.100%
368,594increase
(New Position)
Filing
History
2025-03-05
3:58 pm
Unchanged
2025-03-05 13D Whitehawk Therapeutics Inc
WHWK
BML Investment Partners, L.P. 2,435,000
4.980%
0
(Unchanged)
Filing
History
2025-03-03
2:03 pm
Purchase
2025-02-26 13G LAVA Therapeutics N.V.
LVTX
BML Investment Partners, L.P. 1,958,110
7.400%
1,958,110increase
(New Position)
Filing
History
2025-02-24
11:38 am
Unchanged
2025-02-24 13D Whitehawk Therapeutics Inc
WHWK
BML Investment Partners, L.P. 2,435,000
9.900%
0
(Unchanged)
Filing
History
2025-02-14
11:03 am
Purchase
2025-02-11 13G Third Harmonic Bio, Inc.
THRD
BML Investment Partners, L.P. 3,724,167
8.200%
3,724,167increase
(New Position)
Filing
History
2025-02-14
10:47 am
Unchanged
2024-12-31 13G Ikena Oncology, Inc.
IKNA
BML Investment Partners, L.P. 3,645,866
7.600%
0
(Unchanged)
Filing
History
2025-02-14
10:26 am
Purchase
2024-12-31 13G ESSA Pharma Inc.
EPIX
BML Investment Partners, L.P. 4,221,546
9.500%
38,323increase
(+0.92%)
Filing
History
2025-02-14
10:21 am
Purchase
2024-12-31 13G Athira Pharma, Inc.
ATHA
BML Investment Partners, L.P. 3,027,163
7.800%
542,718increase
(+21.84%)
Filing
History
2025-02-14
10:15 am
Purchase
2024-12-31 13G PMV Pharmaceuticals, Inc.
PMVP
BML Investment Partners, L.P. 3,466,684
6.700%
196,777increase
(+6.02%)
Filing
History
2025-02-14
10:06 am
Unchanged
2024-12-31 13G PMV Pharmaceuticals, Inc.
PMVP
BML Investment Partners, L.P. 3,269,907
6.300%
0
(Unchanged)
Filing
History
2025-02-14
09:59 am
Unchanged
2024-12-31 13G Athira Pharma, Inc.
ATHA
BML Investment Partners, L.P. 2,484,445
6.500%
0
(Unchanged)
Filing
History
2025-02-14
09:49 am
Unchanged
2024-12-31 13G ESSA Pharma Inc.
EPIX
BML Investment Partners, L.P. 4,183,223
9.400%
0
(Unchanged)
Filing
History
2025-02-13
5:02 pm
Unchanged
2024-12-31 13G Achilles Therapeutics plc
ACHL
BML Investment Partners, L.P. 4,100,002
9.970%
0
(Unchanged)
Filing
History
Goto 0, 1, 2, ...5, 6, Next